India Nutritional Supplements Market Analysis Report 2022 to 2030

India Nutritional Supplements Market Analysis

$ 3999

By 2030, it is anticipated that the India Nutrition and Supplements market will reach a value of $16.57 Bn from $6.94 Bn in 2022, growing at a CAGR of 11.5% during 2022-2030. The market is primarily dominated by local players such as Hindustan Unilever Limited, Dabur India Ltd, Cipla Limited, and Zydus Wellness Limited. The market for nutrition and supplements in India is primarily driven by ease of manufacturing, increasing customer awareness, and increasing disposable incomes. The India nutrition and supplements market in India is segmented by Type, Product, application, and Distribution Channel.

ID: IN10INON002 CATEGORY: OTC & Nutraceuticals GEOGRAPHY: India AUTHOR: Dr. Vishwa Modhia

Buy Now

India Nutrition and Supplements Market Analysis Summary

By 2030, it is anticipated that the India Nutrition and Supplements market will reach a value of $16.57 Bn from $6.94 Bn in 2022, growing at a CAGR of 11.5% during 2022-30.

India has a sizable and diverse population with a range of dietary preferences and lifestyles. In India, micronutrient deficiencies like iron deficiency anemia and high rates of undernutrition, stunting, and wasting among children make malnutrition a serious problem. In India, the demand for supplements is rising due to an increased focus on health and wellness as well as a developing middle class with more disposable income. Popular supplements include multivitamins, protein powders, omega-3 fatty acids, and probiotics.

Over 65% of the India nutrition and supplements market is made up of dietary supplements, which include products like macronutrients and herbal and non-herbal extracts. Along with giving room for further market consolidation by international brands like Cargill, Nestle, and Amway, the rising demand for nutraceuticals has also contributed to the emergence of initiatives like HealthKart and Patanjali in India.

india nutrition and supplements market analysis

Market Dynamics

Market Growth Drivers Analysis

According to a World Bank report on "Nutrition in India," malnutrition costs India's Gross Domestic Product (GDP) close to $12 Bn. The benefit-to-cost ratio for interventions to reduce the loss, however, would be about $524 Mn dollars annually, or nearly 23 times.

India is a fierce competitor in the global nutrition and supplement market thanks to its distinct advantages of having a long history and a wealth of knowledge, having access to raw materials, seeing a rise in the production of herbal extracts, and dominating many export markets as a preferred supplier.

Market Restraints

In India, out-of-pocket expenses for healthcare account for 62% of total costs, and 60% of doctors' prescriptions for medication include supplements. There are questions about the quality and safety of many products in the Indian supplement market, which is largely unregulated. Prior to starting any new supplement regimen, it's critical for consumers to choose supplements from reliable brands and to speak with a healthcare provider.

Competitive Landscape

Key Players

GlaxoSmithKline Consumer Healthcare (IND)
Hindustan Unilever Limited (HUL) (IND)
Dabur India Ltd. (IND)
Sun Pharma Advanced Research Company (SPARC) (IND)
Cipla Limited (IND)
Zydus Wellness Limited (IND)
Himalaya Drug Company (IND)
Abbott India Limited (IND)
Lupin Limited (IND)
ITC Limited (IND)

Notable Recent Deals

July 2022: Endura Mass, a nutritional supplement brand in the weight gain category, will be acquired by Cipla Health Limited (CHL), the consumer health division of Cipla, for an undisclosed sum. Endura Mass was developed by Medinn Belle Herbal Care Private Limited. The acquisition would include Endura and all related trademarks. While the proposed acquisition is being finalized, CHL will start the distribution and marketing of Endura Mass.

Healthcare Policies and Reimbursement Scenarios

The Food Safety and Standards Authority of India (FSSAI) is in charge of regulating dietary supplements and nutrition in India. The FSSAI is in charge of establishing requirements for food products' quality and safety, including those containing dietary supplements. It also keeps track of compliance and enforces compliance.

The reimbursement of dietary supplements and nutrition products in India is constrained and primarily determined by medical necessity. Supplemental insurance reimbursement is frequently constrained and available only through private health insurance plans. The cost of dietary supplements is typically not covered by publicly funded health insurance programs, such as the Rashtriya Swasthya Bima Yojana unless a doctor has prescribed them for a specific medical condition.

1. Executive Summary
1.1 Product Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Government Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel and Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

Nutritional Supplements Market Segmentation

The Nutritional Supplements Market is segmented as mentioned below:

By Product (Revenue, USD Billion):

Sports Nutrition
- Sports Food
- Sports Drinks
- Sports Supplements

Fat Burners
- Green Tea
- Fiber
- Protein
- Green Coffee
- Others (Turmeric, Ginseng, Cranberry, Garcinia Cambogia)?

Dietary Supplements
- Vitamins
- Minerals
- Enzymes
- Amino Acids
- Conjugated Linoleic Acids

Functional Foods
- Probiotics
- Omega-3
- Others

By Consumer Group (Revenue, USD Billion):

Infant
Children
Adults
Pregnant
Geriatric

By Formulation (Revenue, USD Billion):

Tablets
Capsules
Powder
Softgels
Liquid
Others

By Delivery Channel (Revenue, USD Billion):

Chemists/Pharmacists
Direct-to-Consumer Sales
E-commerce

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.